Skip to content
Lower risk Medical device recall · FDA · Published November 3, 2023

Medtronic ICM LNQ22 LINQ II Insertable Cardiac Monitor: Potential Signal Interference

Medtronic recalls specific models of ICM LNQ22 LINQ II insertable cardiac monitors due to potential signal interference that may affect heart rhythm recordings. This issue differs from normal noise patterns caused by device movement or external factors.

🇺🇸 FDA recall #Z-0421-2024Medical deviceMedtronic ›
Take action

Contact the company

Recalling firmMedtronic Inc.8200 Coral Sea St Ne · Mounds View, MN 55112-4391
✎ GovInfoNow plain-language explainer

What happened, in plain English

Medtronic is recalling certain ICM LNQ22 LINQ II insertable cardiac monitors because they may cause signal interference that affects heart rhythm recordings. This is different from typical noise from device movement or external interference. Read more at govinfonow.com/recall/56948-medtronic-icm-lnq22-linq-ii-insertable-cardiac-monitor-potential-signal.

Source Summary by GovInfoNow · govinfonow.com/recall/56948-medtronic-icm-lnq22-linq-ii-insertable-cardiac-monitor-potential-signal · Updated August 17, 2026 · FDA enforcement record: FDA #Z-0421-2024

Cite this page

“Medtronic ICM LNQ22 LINQ II Insertable Cardiac Monitor: Potential Signal Interference.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/56948-medtronic-icm-lnq22-linq-ii-insertable-cardiac-monitor-potential-signal. Based on FDA recall #Z-0421-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0421-2024%22&limit=1).

Why it’s dangerous

The device may create amplified noise and signal reduction that interferes with heart rhythm recordings. This pattern is different from normal noise caused by device movement, patient activity, or external electromagnetic interference.

Who’s affected

Patients with Medtronic ICM LNQ22 LINQ II insertable cardiac monitors who have the specific serial numbers listed in the recall are affected. The risk is low as the issue does not cause serious injury but may affect monitoring accuracy.

How to tell if you have this one

Check your insertable cardiac monitor's serial number against the list of affected units provided in the recall notice. The affected models are ICM LNQ22 LINQ II with specific serial numbers listed in the record.

  • Brand
    Medtronic
  • Product
    Medtronic Inc. recalls ICM LNQ22 LINQ II, Model LNQ22; Insertable Cardiac Monitor
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Serial Number

    Compare your device's serial number with the list of affected units provided in the recall notice.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “US and Australia, Austria, Belgium, Brunei Darussalam, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Iceland, Ireland, Israel, Italy, Japan, Liechtenstein, Luxembourg, Macao, Malaysia, Netherlands, New…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 33 days after the firm started it.

1. Firm started the recall: Nov 3, 202312. FDA classified it Class II: Nov 30, 202323. Published in FDA’s Enforcement Report: Dec 6, 202332023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Medtronic recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0421-2024 (November 3, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0421-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA